The major goal of this proposal is to further define the genetic contribution to the immunopathogenesis of insulin-dependent diabetes mellitus in NOD mice. Experiments are proposed to test the hypothesis that the NOD I-A locus with or without novel T cell receptor genes is necessary for the development of T cell specificities involved in disease. We will also determine if homozygosity for the NOD I-A locus required for disease and the mechanism by which the introduction of unrelated I-A genes prevents the development of disease. Experiments will initially be performed to confirm that the major histocompatibility complex (MHC) of NOD mice rather than another closely linked locus is involved in the development of insulitis. This will be accomplished by correlating insulitis and MHC genotype in various backcross combinations. Similar analyses will determine if NOD T cell receptor alpha- or beta- chain gene complexes contribute in a recessive or dominant manner to the pathogenesis of disease. The requirement for homozygosity of the NOD MHC in the development of insulitis will be determined in genetic backcrosses involving different non- NOD H-2 haplotypes that have similarities with that of the NOD. If a particular MHC allows for disease in heterozygous backcross mice, the possibility that it supplants the need for the NOD MHC will be tested by further inbreeding. In backcrosses where homozygosity is required, experiments are designed to test whether (1) peripheral expression of NOD I-A antigens correlates with the ability of a non-NOD MHC to suppresses disease and (2) whether the prevention of disease occurs at the level of the thymus. The latter studies will involve transplanting NOD vs. F1 thymus grafts into NOD mice that had previously been thymectomized, lethally irradiated, and reconstituted with T cell- depleted bone marrow. Finally, experiments are proposed to test whether the NOD MHC (plus or minus NOD T cell receptor gene complexes) is sufficient for the development of T cells that can mediate disease or whether other NOD gene loci are also required. This will involve the breeding of mice (B10 background) congenic for the NOD MHC (B10.NOD mice) and possibly mice congenic for a particular NOD T cell receptor gene complex. T cells from these congenic mice will be compared with those from NOD mice in the ability to transfer disease to T cell-depleted NOD or to irradiated B10.NOD recipients.

Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Peterson, J D; Haskins, K (1996) Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells. Diabetes 45:328-36
Sellins, K S; Gold, D P; Bellgrau, D (1996) Resistance to tolerance induction in the diabetes-prone biobreeding rat as one manifestation of abnormal responses to superantigens. Diabetologia 39:28-36
Gold, D P; Shaikewitz, S T; Mueller, D et al. (1995) T cells from BB-DP rats show a unique cytokine mRNA profile associated with the IDDM1 susceptibility gene, Lyp. Autoimmunity 22:149-61
Peterson, J D; Pike, B; Dallas-Pedretti, A et al. (1995) Induction of diabetes with islet-specific T-cell clones is age dependent. Immunology 85:455-60
Peterson, J D; Pike, B; McDuffie, M et al. (1994) Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice. J Immunol 153:2800-6
Bellgrau, D; Redd, J M; Sellins, K S (1994) Peculiar T-cell signaling does not preclude positive selection in the diabetes-prone BB rat. Diabetes 43:47-52
Bergman, B; Haskins, K (1994) Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes 43:197-203
Shehadeh, N N; Gill, R G; Lafferty, K J (1993) Mechanism of self-tolerance to endocrine tissue. Springer Semin Immunopathol 14:203-20
Hayward, A R; Shriber, M; Cooke, A et al. (1993) Prevention of diabetes but not insulitis in NOD mice injected with antibody to CD4. J Autoimmun 6:301-10
Shehadeh, N N; LaRosa, F; Lafferty, K J (1993) Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 6:291-300

Showing the most recent 10 out of 29 publications